Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

OBIO | Orchestra BioMed Holdings Inc

Index	RUT	P/E	-	EPS (ttm)	-0.87	Insider Own	38.65%	Shs Outstand	35.74M	Perf Week	1.63%
Market Cap	311.65M	Forward P/E	-	EPS next Y	-1.49	Insider Trans	0.00%	Shs Float	21.93M	Perf Month	27.86%
Income	-24.55M	PEG	-	EPS next Q	-0.39	Inst Own	29.47%	Short Float / Ratio	3.03% / 4.79	Perf Quarter	24.57%
Sales	2.08M	P/S	149.83	EPS this Y	89.66%	Inst Trans	-31.26%	Short Interest	0.66M	Perf Half Y	-43.67%
Book/sh	2.50	P/B	3.48	EPS next Y	1.55%	ROA	-17.08%	Target Price	20.50	Perf Year	-11.97%
Cash/sh	3.30	P/C	2.65	EPS next 5Y	-	ROE	-20.10%	52W Range	4.85 - 23.39	Perf YTD	-12.63%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-24.47%	52W High	-62.72%	Beta	-0.23
Dividend %	-	Quick Ratio	10.07	Sales past 5Y	0.00%	Gross Margin	73.30%	52W Low	79.79%	ATR	1.02
Employees	4	Current Ratio	10.08	Sales Q/Q	-	Oper. Margin	-1259.79%	RSI (14)	58.41	Volatility	10.77% 15.29%
Optionable	No	Debt/Eq	0.13	EPS Q/Q	-869.36%	Profit Margin	-1180.78%	Rel Volume	0.76	Prev Close	7.70
Shortable	Yes	LT Debt/Eq	0.12	Earnings	Aug 10 AMC	Payout	-	Avg Volume	138.46K	Price	8.72
Recom	1.00	SMA20	20.29%	SMA50	31.71%	SMA200	-21.18%	Volume	104,977	Change	13.25%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-24-23	Initiated	Piper Sandler	Overweight	$15
Feb-07-23	Initiated	Chardan Capital Markets	Buy	$20

Sep-22-23 11:27AM	Lab Notes: Main Line firm spins off company that will focus on OTC product pipeline (American City Business Journals)
Sep-19-23 02:37PM	Rebel's Edge - September 19: $NIO, $BHC, $OBIO, and the Firing of MSU's Football Coach (TheStreet.com) +27.61%
07:30AM	Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT for the Treatment of Hypertension in Pacemaker Patients (GlobeNewswire)
Sep-06-23 05:00PM	Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors (GlobeNewswire)
Aug-10-23 04:34PM	Orchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +7.05%
08:30AM	Loading…
Aug-08-23 08:30AM	Orchestra BioMed Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon in Patients with Coronary In-Stent Restenosis (GlobeNewswire)
Jul-27-23 09:47AM	Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) stock most popular amongst retail investors who own 36%, while hedge funds hold 28% (Simply Wall St.) -14.00%
Jun-28-23 02:16PM	Why Shares of Orchestra BioMed Holdings Jumped Wednesday (Motley Fool) +24.85%
Jun-26-23 08:00AM	Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes (GlobeNewswire) -9.81%
Jun-07-23 08:30AM	Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer (GlobeNewswire) -6.42%
Jun-01-23 08:00AM	Orchestra BioMed to Present at the Jefferies Global Healthcare Conference (GlobeNewswire) +8.93%
May-12-23 09:15AM	Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-11-23 05:39AM	3 Stocks That Already Doubled in 2023 and Could Keep Climbing (Motley Fool) +10.12%
Mar-27-23 06:05AM	Orchestra BioMed Holdings Full Year 2022 Earnings: US$14.60 loss per share (vs US$10.90 loss in FY 2021) (Simply Wall St.)
Mar-24-23 03:52PM	Why Shares of Orchestra BioMed Jumped This Week (Motley Fool)
08:00AM	Loading…
Mar-07-23 08:00AM	Orchestra BioMed to Present at Upcoming Investor Conferences (GlobeNewswire) -6.77%
Feb-24-23 08:00AM	Orchestra BioMed Announces Upcoming Presentations on BackBeat CNT and Virtue® SAB at CRT 2023 (GlobeNewswire)
Feb-07-23 08:00AM	Orchestra BioMed Strengthens Senior Leadership Team (GlobeNewswire)

Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded on May 25, 2020 and is headquartered in New Hope, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ROSE ERIC A MD	Director	May 17	Option Exercise	1.08	2,325	2,511	2,325	May 19 06:15 PM
Fain Eric S	Director	May 10	Option Exercise	1.08	2,906	3,138	29,767	May 12 04:59 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OBIO | Orchestra BioMed Holdings Inc

Upgrade your FINVIZ experience